7-OH vs. Morphine: How Strong Is 7-Hydroxymitragynine?
7-OH (7-hydroxymitragynine) has demonstrated greater potency than morphine in certain laboratory and animal studies, but researchers have not established that it is a specific number of times stronger in humans. Its effects depend on the experimental conditions, the outcome being measured, and how the substance enters the body.
You may have seen claims that 7-OH is 13 times stronger than morphine. While this comparison comes from preclinical research, it does not mean that 7-OH and morphine have interchangeable doses or equivalent effects in people.
Understanding 7-OH vs. morphine is particularly important as concentrated 7-OH products become more widely available. Unlike traditional kratom leaf, these products may contain significantly higher concentrations of 7-hydroxymitragynine, raising concerns about dependence, withdrawal, and respiratory depression.
If you’re experiencing difficulty reducing your use, DevotedDOc offers kratom addiction treatment evaluations to help determine appropriate care options.
Medical content reviewed by Dr. Matthew Berrios, DO, CEO of DevotedDOc. This article is for educational purposes only and does not replace individualized medical advice. Animal-study potency findings should not be used to calculate human doses or substitute 7-OH for prescribed opioids.
Is 7-OH Stronger Than Morphine?
Some laboratory and animal studies have found that 7-hydroxymitragynine produces certain opioid-related effects at lower amounts than morphine. However, there is no established human dose equivalency between 7-OH and morphine.
A 2006 study published in the European Journal of Pharmacology compared the pain-response effects of 7-hydroxymitragynine and morphine in mice. Researchers found that 7-OH was approximately 5.7 times more potent in the tail-flick test and 4.4 times more potent in the hot-plate test.
These findings suggest that 7-OH has substantial opioid activity. However, the study involved mice receiving substances through subcutaneous injection, not people taking commercial 7-OH products.
The peer-reviewed study on 7-hydroxymitragynine and opioid receptors helps explain why these comparisons are scientifically relevant but cannot establish how much stronger 7-OH is in humans.
Why Do Some Sources Say 7-OH Is 13 Times Stronger Than Morphine?
The frequently repeated claim that 7-OH is 13 times stronger than morphine comes from earlier preclinical research involving isolated tissue.
In these experiments, researchers evaluated how the substances affected opioid-related responses in laboratory preparations. The findings demonstrated greater potency for 7-OH under those specific conditions.
However, these experiments did not measure pain relief in humans or establish how concentrated 7-OH products compare with prescribed morphine.
A scientific review published in ACS Medicinal Chemistry Letters discusses the pharmacology of kratom alkaloids and the limitations of interpreting experimental potency findings.
For patients, the important distinction is that a laboratory potency comparison does not establish an equivalent human dose, overall effectiveness, or relative safety.
What Is 7-Hydroxymitragynine?
7-Hydroxymitragynine, commonly called 7-OH, is an opioid-active alkaloid associated with the kratom plant, Mitragyna speciosa.
Traditional kratom leaves contain several alkaloids, primarily mitragynine, along with much smaller amounts of naturally occurring 7-OH. The body can also produce 7-hydroxymitragynine when it metabolizes mitragynine.
However, some commercial products contain concentrated or chemically enhanced 7-OH at levels substantially higher than those found naturally in kratom leaves.
These products may be sold as tablets, gummies, liquids, or other formulations marketed for their opioid-like effects.
To understand the compound’s effects and how it differs from traditional kratom, read our guide on what is 7-OH.
How Does 7-OH Work in the Body?
7-OH interacts with mu-opioid receptors, which play an important role in pain perception, sedation, and other opioid-related effects.
Morphine also acts on these receptors, but the two substances have different chemical structures and pharmacological characteristics.
Research indicates that 7-OH can produce opioid-like effects, including pain-response suppression in animals, tolerance, dependence, and withdrawal.
However, 7-OH is not an FDA-approved medication, and its safety and effectiveness for treating pain or opioid withdrawal have not been established.
7-OH vs. Morphine: What Are the Main Differences?
Although 7-OH and morphine affect the same general opioid receptor system, their medical uses, available research, and product regulation differ significantly.
| Comparison | 7-Hydroxymitragynine (7-OH) | Morphine |
| Origin | Kratom-associated alkaloid; concentrated forms may be chemically produced | Opioid medication derived from opium alkaloids |
| Opioid activity | Acts on mu-opioid receptors | Acts on mu-opioid receptors |
| FDA-approved medical use | None | Approved for certain pain conditions |
| Human clinical research | Limited | Extensive |
| Potency comparison | More potent in some animal and laboratory tests | Common reference opioid in research |
| Dependence potential | Yes | Yes |
| Respiratory depression | Reported and supported by preclinical findings | Well-established serious risk |
| Product consistency | Commercial concentrated products may vary | Pharmaceutical products have regulated manufacturing standards |
The most important difference is not simply which substance appears stronger in a study. Morphine is an approved prescription medication with established clinical guidance, while concentrated 7-OH products have not been proven safe or effective for medical treatment.
Why 7-OH Product Strength Can Be Unpredictable
Commercial 7-OH products may be advertised as high-potency kratom or enhanced extracts, but these descriptions do not necessarily reflect consistent concentrations or reliable labeling.
Some products contain substantially higher amounts of 7-OH than traditional botanical preparations. Others may contain additional alkaloids or ingredients that consumers are not aware of.
This makes it difficult to predict how a product will affect someone, particularly when other medications or substances are involved.
What Does 7-OH Potency Actually Mean?
In pharmacology, potency refers to the amount of a substance required to produce a particular measured effect.
A more potent substance can produce that effect at a lower amount, but this does not necessarily mean it produces a greater maximum effect.
Potency and effectiveness are related but different concepts. Researchers also distinguish them from safety, which depends on factors such as adverse effects, exposure, and individual health conditions.
Why Animal Studies Cannot Determine Human Strength
Animal studies help researchers understand how substances interact with receptors and affect biological processes.
However, findings from these studies cannot always be applied directly to humans. Differences in metabolism, absorption, receptor responses, and routes of administration can influence how substances behave.
For example, a substance administered through an injection in mice may behave differently from a commercially available product taken orally by a person.
This is particularly relevant when comparing 7-OH with morphine because much of the available potency research involves laboratory or animal models.
There is no clinically validated conversion formula for replacing prescribed morphine with concentrated 7-OH. Patients should never use experimental potency ratios to determine how much of either substance to take.
Is 7-OH Stronger Than Traditional Kratom?
Concentrated 7-OH products can produce substantially different opioid-related effects from traditional kratom leaf because they contain much higher concentrations of 7-hydroxymitragynine.
Traditional kratom contains multiple naturally occurring alkaloids, with mitragynine generally being the most abundant. By comparison, some enhanced commercial products contain concentrated 7-OH as a primary active ingredient.
This distinction is important because products marketed under the kratom name do not necessarily have the same chemical composition or risk profile.
Our comparison of kratom vs. 7-OH explains how their ingredients, effects, and potential risks differ.
Does Higher 7-OH Potency Mean Greater Health Risks?
Higher concentrations of an opioid-active substance can increase the potential for significant opioid-related effects, particularly when exposure is difficult to predict.
However, potency alone does not determine the likelihood or severity of an overdose. Other factors, including product composition, route of administration, tolerance, and concurrent substance use, also matter.
The FDA warns that concentrated 7-OH products can cause serious harm, including addiction, seizures, withdrawal symptoms, and other adverse effects.
The agency recommends avoiding these products because they have not been established as safe or effective for any medical use.
Can 7-OH Cause Respiratory Depression Like Morphine?
Yes. Concentrated 7-OH can cause opioid-related respiratory depression, a condition in which breathing becomes dangerously slow or shallow.
Morphine’s respiratory depressant effects are well established. Evidence from animal studies and clinical experience also indicates that 7-OH can interfere with normal breathing.
The American College of Medical Toxicology reported in its August 2026 position statement that concentrated 7-OH products have been associated with intoxication, respiratory depression, dependence, overdose, and death.
The organization also discusses preclinical research demonstrating that 7-OH can reduce breathing frequency and ventilation.
These findings establish a serious safety concern, but they do not provide a reliable way to compare the overdose risk of 7-OH and morphine in humans at equivalent doses.
What Are the Warning Signs of Serious 7-OH Toxicity?
Possible warning signs include extreme drowsiness, confusion, difficulty waking someone, slow or irregular breathing, and loss of consciousness.
Combining concentrated 7-OH with alcohol, benzodiazepines, prescription opioids, or other sedating substances may increase the risk of dangerous respiratory depression.
If someone is unresponsive or not breathing normally after suspected 7-OH exposure, call 911 immediately. Administer naloxone if available, follow emergency dispatcher instructions, and stay with the person until help arrives.
Naloxone may reverse opioid-related respiratory depression. However, emergency medical care is still necessary, even if the person initially improves.
Can 7-OH Cause Dependence and Withdrawal?
Yes. Repeated exposure to concentrated 7-OH can lead to physical dependence, meaning the body adapts to the substance over time.
When someone who has developed physical dependence reduces or stops use, withdrawal symptoms may occur.
These symptoms can include restlessness, anxiety, sweating, muscle aches, gastrointestinal discomfort, sleep disturbances, and cravings.
A 2005 study published in Life Sciences found that repeated 7-OH exposure in mice produced tolerance, cross-tolerance with morphine, and withdrawal-related effects.
Although these findings come from animal research, they support concerns about the opioid-like dependence potential of 7-hydroxymitragynine.
How Does 7-OH Withdrawal Compare With Morphine Withdrawal?
7-OH withdrawal may share symptoms with withdrawal from other opioids, including morphine. However, the severity and duration of symptoms can vary depending on the individual, the product used, and the pattern of exposure.
Current research does not establish a reliable way to predict how 7-OH withdrawal will compare with morphine withdrawal in every patient.
People who regularly use concentrated products may benefit from medical evaluation, especially if they experience significant withdrawal symptoms or have difficulty reducing their use.
You can also learn about common symptoms and treatment considerations in our article on kratom and 7-OH withdrawal.
Can Suboxone Help With 7-OH Dependence?
For patients experiencing opioid-related dependence, professional treatment may help address withdrawal symptoms, cravings, and ongoing substance use.
Buprenorphine, one of the active ingredients in Suboxone, is an established medication for opioid use disorder.
Healthcare providers have also reported using buprenorphine-based treatment in selected cases involving kratom and concentrated 7-OH dependence.
However, research specifically evaluating treatment for 7-OH dependence remains limited, and there is no universally established medication protocol for these products.
Why Medical Evaluation Matters Before Starting Treatment
A healthcare provider needs to assess a patient’s substance use history, withdrawal symptoms, other medications, and overall health before recommending treatment.
Starting buprenorphine at an inappropriate time after certain opioid exposures can cause precipitated withdrawal, a sudden worsening of withdrawal symptoms.
For patients considering medication-based care, understanding Suboxone treatment after 7-OH use can help explain why treatment timing and medical supervision matter.
DevotedDOc provides online Suboxone treatment for eligible patients when clinically appropriate, including physician-led evaluations, medication management, and ongoing follow-up appointments.
Frequently Asked Questions About 7-OH vs. Morphine
Is 7-OH stronger than morphine?
Some laboratory and animal studies have found 7-OH to be more potent than morphine for specific measured effects. However, human clinical evidence is insufficient to establish one universal potency comparison.
Is 7-OH really 13 times stronger than morphine?
The widely cited 13-times comparison comes from preclinical laboratory research. It does not establish that 7-OH is 13 times stronger than morphine in humans or that their doses are interchangeable.
Is 7-hydroxymitragynine an opioid?
7-Hydroxymitragynine is a kratom-associated alkaloid with opioid activity. It acts on mu-opioid receptors and can produce effects associated with opioids, including dependence and potentially dangerous respiratory depression.
Is 7-OH stronger than kratom?
Concentrated 7-OH products may produce stronger opioid-related effects than traditional kratom leaf because they contain substantially higher concentrations of 7-hydroxymitragynine.
Can 7-OH cause an overdose?
Yes. Concentrated 7-OH products have been associated with serious toxicity, including respiratory depression, overdose, and death. Suspected overdose requires immediate emergency medical attention.
Is 7-OH safer than morphine because it comes from kratom?
No. A substance’s natural origin does not establish its safety. Concentrated 7-OH products have not been approved by the FDA for medical use, and their safety profile remains incompletely understood.
Can 7-OH replace prescribed morphine?
No. Patients should not substitute concentrated 7-OH for prescribed morphine or other opioid medications. There is no validated human dose conversion, and 7-OH products are not FDA-approved alternatives to prescription pain medications.
Get Support for 7-OH Dependence With DevotedDOc
Research comparing 7-OH vs. morphine shows that 7-hydroxymitragynine has potent opioid activity, but laboratory findings do not establish exactly how strong it is in humans.
For patients, the most important consideration is that concentrated 7-OH products can cause dependence, withdrawal, and potentially dangerous respiratory depression, regardless of how their strength is advertised.
If you regularly use concentrated 7-OH, experience withdrawal symptoms, or struggle to reduce your use, a healthcare provider can help evaluate your situation and discuss appropriate treatment options.
DevotedDOc offers physician-led online opioid addiction treatment, including clinical evaluations, medication management when appropriate, and ongoing recovery support.
Concerned about 7-OH dependence? Schedule an online appointment with DevotedDOc to discuss your symptoms and available treatment options.